Medesis Pharma SA Net Asset Momentum

Latest YoY growth as of December 2023: -325.4%

Medesis Pharma SA net asset momentum. Medesis Pharma SA (ALMDP) recorded a net asset momentum of -325.4% as of December 2023, with net assets of €-4.50 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check ALMDP cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

YoY Momentum

-325.4%
Year-over-year

Current Net Assets

€-4.50 Million
EUR · December 2023

Years of Data

6
2018 – 2023

Country

France
PA

Net Asset Momentum of Medesis Pharma SA (2018–2023)

Net asset momentum of Medesis Pharma SA from 2018 to 2023. This chart tracks Medesis Pharma SA's year-over-year net asset growth across 6 annual reporting periods from 2018 to 2023. The most recent momentum reading is -325.4%, with net assets of €-4.50 Million EUR as of December 2023. See ALMDP net asset value for net asset value and shareholders' equity analysis.

Medesis Pharma SA Net Asset Momentum by Year (2018–2023)

Medesis Pharma SA net asset momentum by year from 2018 to 2023. The table below shows the complete annual net asset history for Medesis Pharma SA from 2018 to 2023, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market cap of Medesis Pharma SA.

Year Net Assets (EUR) Total Assets Total Liabilities YoY Momentum
2023 €-4.50 Million €1.93 Million €6.43 Million ▼ -325.4%
2022 €-1.06 Million €1.92 Million €2.97 Million ▼ -164.3%
2021 €1.65 Million €4.33 Million €2.68 Million ▲ +179.0%
2020 €-2.08 Million €837.91K €2.92 Million ▲ +13.9%
2019 €-2.42 Million €714.00K €3.13 Million ▼ -176.0%
2018 €-876.00K €1.62 Million €2.50 Million —